ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD

Wen, Ling; Li, Minyan; Lin, Xiaojun; Li, Yan; Song, Huidong*; Chen, Hanqing*广州医学院; 1
Frontiers in Bioengineering and Biotechnology2022-5-19DOI: 10.3389/fbioe.2022.912178
11被引15阅读
引用收藏
分享

摘要

The recent development of silver nanoparticles (AgNPs) has sparked increased interest in biomedical and pharmaceutical applications, leading to the possibility of human exposure. The liver is the primary target organ in the metabolism and transport of nanoparticles. Non-alcoholic fatty liver disease (NAFLD) is the most common and leading cause of hepatic metabolic syndrome with approximately 15% of patients will develop into non-alcoholic steatohepatitis, fibrosis, cirrhosis, and eventually hepatocellular carcinoma. Thus, the potential hepatotoxicity of AgNPs on NAFLD development and progression should be of great concern. Herein, we explored the potential hepatic effect of a single intravenously injected dose of 0.5, 2.5, and 12.5 mg/kg BW on the liver function of high-fat-diet (HFD)-fed mice for 7 days. AgNP treatment increased serum levels of alanine aminotransferase, aspartate transaminase, triglycerides and cholesterols, the number of lipid droplets, and the contents of triglycerides and cholesterols in NAFLD mice livers compared to HFD-fed mice. The mechanism of AgNP-induced worsen hepatotoxicity in mice is associated with hyperactivation of SREBP-1c-mediated de novo lipogenesis and liver inflammation. Additionally, HFD-fed mice treated with AgNPs had significantly higher oxidative damage and lower global DNA methylation and DNA hydroxymethylation than NAFLD mice. This study suggests that AgNP treatment exacerbated HFD-induced hepatic steatosis, liver inflammation, oxidative stress, and epigenetic changes in mice, which is relevant to the risk of AgNP exposure on NAFLD development and progression.

学科与关键词

关键词
silver nanoparticlesnon-alcoholic fatty liver diseasehepatic steatosisglobal DNA methylationliver inflammationhepatotoxicity
相关
加载中…
  • Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload
    Zhu, Meilin; Chen, Hanqing*; Zhou, Shuang; Zheng, Lingna; Li, Xue; Chu, Runxuan; Chen, Wei; Wang, Bing; Wang, Meng; Chai, Zhifang; Feng, Weiyue*Nanotoxicology, 2021, 15(6): 761-778.被引 17
  • Hepatic impacts of gold nanoparticles with different surface coatings as revealed by assessing the hepatic drug-metabolizing enzyme and lipid homeostasis in mice
    Zhou, Shuang; Li, Xue; Zhu, Meilin; Yu, Hongyang; Chu, Runxuan; Chen, Wei; Wang, Bing; Wang, Meng; Zheng, Lingna; Chai, Zhifang; Chen, Hanqing*; Feng, Weiyue*NanoImpact, 2020, 20: 100259.被引 13
  • Gold Nanoparticles Modified With Polyethyleneimine Disturbed the Activity of Drug-Metabolic Enzymes and Induced Inflammation-Mediated Liver Injury in Mice
    Chen, Hanqing*; Zhou, Shuang; Zhu, Meilin; Wang, Bing; Chen, Wei; Zheng, Lingna; Wang, Meng; Feng, Weiyue*Frontiers in Pharmacology, 2021, 12: 706791.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Bioengineering and Biotechnology
发表日期
2022-05-19
卷期
第 10 卷
页码
912178
DOI
10.3389/fbioe.2022.912178
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [32171370, 11505193]; Natural Science Foundation of Guangdong Province [2022A1515010415]; Research Foundation of Guangzhou First Peoples Hospital [KY09040029]

作者

  • W

    Wen, Ling (第一作者)

  • L

    Li, Minyan

查看全部 6 位作者收起作者
  • L

    Lin, Xiaojun

    guangzhou med univ

  • L

    Li, Yan

  • S

    Song, Huidong (通讯)

  • C

    Chen, Hanqing (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417